Download
s12874-021-01359-x.pdf 2,11MB
WeightNameValue
1000 Titel
  • Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
1000 Autor/in
  1. Blümle, Anette |
  2. Wollmann, Katharina |
  3. Bischoff, Karin |
  4. Kapp, Philipp |
  5. Lohner, Szimonetta |
  6. Nury, Edris |
  7. Nitschke, Kai |
  8. Zähringer, Jasmin |
  9. Rücker, Gerta |
  10. Schumacher, Martin |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-08-31
1000 Erschienen in
1000 Quellenangabe
  • 21(1):182
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12874-021-01359-x |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406615/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Healthcare decisions are ideally based on clinical trial results, published in study registries, as journal articles or summarized in secondary research articles. In this research project, we investigated the impact of academically and commercially sponsored clinical trials on medical practice by measuring the proportion of trials published and cited by systematic reviews and clinical guidelines.!##!Methods!#!We examined 691 multicenter, randomized controlled trials that started in 2005 or later and were completed by the end of 2016. To determine whether sponsorship/funding and place of conduct influence a trial's impact, we created four sub-cohorts of investigator initiated trials (IITs) and industry sponsored trials (ISTs): 120 IITs and 171 ISTs with German contribution compared to 200 IITs and 200 ISTs without German contribution. We balanced the groups for study phase and place of conduct. German IITs were funded by the German Research Foundation (DFG), the Federal Ministry of Education and Research (BMBF), or by another non-commercial research organization. All other trials were drawn from the German Clinical Trials Register or ClinicalTrials.gov. We investigated, to what extent study characteristics were associated with publication and impact using multivariable logistic regressions.!##!Results!#!For 80% of the 691 trials, results were published as result articles in a medical journal and/or study registry, 52% were cited by a systematic review, and 26% reached impact in a clinical guideline. Drug trials and larger trials were associated with a higher probability to be published and to have an impact than non-drug trials and smaller trials. Results of IITs were more often published as a journal article while results of ISTs were more often published in study registries. International ISTs less often gained impact by inclusion in systematic reviews or guidelines than IITs.!##!Conclusion!#!An encouraging high proportion of the clinical trials were published, and a considerable proportion gained impact on clinical practice. However, there is still room for improvement. For publishing study results, study registries have become an alternative or complement to journal articles, especially for ISTs. IITs funded by governmental bodies in Germany reached an impact that is comparable to international IITs and ISTs.
1000 Sacherschließung
lokal Practice guidelines as topic
lokal Registries
lokal Access to information
lokal Humans [MeSH]
lokal Data collection, quality, and reporting
lokal Multicenter Studies as Topic [MeSH]
lokal Systematic reviews as topic
lokal Research Design [MeSH]
lokal Health impact assessment
lokal Publishing
lokal Randomized Controlled Trials as Topic [MeSH]
lokal Research Personnel [MeSH]
lokal Germany [MeSH]
lokal Knowledge translation
lokal Evidence-based medicine
lokal Clinical decision-making
lokal Research Article
lokal Randomized controlled trials as topic
lokal Registries [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-2877-1029|https://frl.publisso.de/adhoc/uri/V29sbG1hbm4sIEthdGhhcmluYQ==|https://frl.publisso.de/adhoc/uri/QmlzY2hvZmYsIEthcmlu|https://frl.publisso.de/adhoc/uri/S2FwcCwgUGhpbGlwcA==|https://frl.publisso.de/adhoc/uri/TG9obmVyLCBTemltb25ldHRh|https://frl.publisso.de/adhoc/uri/TnVyeSwgRWRyaXM=|https://frl.publisso.de/adhoc/uri/Tml0c2Noa2UsIEthaQ==|https://frl.publisso.de/adhoc/uri/WsOkaHJpbmdlciwgSmFzbWlu|https://frl.publisso.de/adhoc/uri/UsO8Y2tlciwgR2VydGE=|https://frl.publisso.de/adhoc/uri/U2NodW1hY2hlciwgTWFydGlu
1000 Hinweis
  • DeepGreen-ID: abed6e629a034d8ba4b4b50026e1c5f8 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6443542.rdf
1000 Erstellt am 2023-04-27T09:44:14.104+0200
1000 Erstellt von 322
1000 beschreibt frl:6443542
1000 Zuletzt bearbeitet 2023-10-19T15:00:08.076+0200
1000 Objekt bearb. Thu Oct 19 15:00:08 CEST 2023
1000 Vgl. frl:6443542
1000 Oai Id
  1. oai:frl.publisso.de:frl:6443542 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source